Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine
2007

Rikkunshi-to Reduces Nausea from Fluvoxamine

Sample size: 50 publication Evidence: moderate

Author Information

Author(s): Oka Takakazu, Tamagawa Yoko, Hayashida Sota, Kaneda Yuko, Kodama Naoki, Tsuji Sadatoshi

Primary Institution: University of Occupational and Environmental Health

Hypothesis

Rikkunshi-to might attenuate SSRI-induced GI symptoms and potentiate the antidepressant effect of SSRIs.

Conclusion

Rikkunshi-to reduces fluvoxamine-induced adverse events, especially nausea, and improves quality of life related to gastrointestinal symptoms without affecting the antidepressant effect of fluvoxamine.

Supporting Evidence

  • The FLV+TJ-43 group had significantly fewer patients reporting adverse events compared to the FLV group.
  • Nausea was reported by 12% of patients in the FLV+TJ-43 group compared to 36% in the FLV group.
  • Quality of life related to GI symptoms improved in the FLV+TJ-43 group after two weeks of treatment.

Takeaway

This study shows that a herbal medicine called Rikkunshi-to can help people taking fluvoxamine feel less sick to their stomach.

Methodology

Fifty patients with depressive disorder were treated with fluvoxamine alone or in combination with Rikkunshi-to for eight weeks, comparing adverse events and symptom scores.

Potential Biases

Potential bias due to the lack of a placebo control group.

Limitations

The study did not include a placebo group for comparison, which may introduce bias.

Participant Demographics

Patients aged 19–78 years, mean age 40.2 years, with no significant differences in demographics between groups.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1751-0759-1-21

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication